HRT Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-127,998
Closed -$453K 2232
2025
Q1
$453K Buy
+127,998
New +$453K ﹤0.01% 1334
2024
Q4
Sell
-81,291
Closed -$263K 2168
2024
Q3
$263K Buy
81,291
+51,748
+175% +$167K ﹤0.01% 1707
2024
Q2
$56K Buy
+29,543
New +$56K ﹤0.01% 1647
2024
Q1
Sell
-42,192
Closed -$621K 2134
2023
Q4
$621K Buy
42,192
+16,098
+62% +$237K ﹤0.01% 1152
2023
Q3
$477K Sell
26,094
-23,112
-47% -$422K ﹤0.01% 1275
2023
Q2
$1.06M Sell
49,206
-44,584
-48% -$961K 0.01% 853
2023
Q1
$2.75M Buy
+93,790
New +$2.75M 0.03% 435